New York Times examines debate surrounding China's family planning laws

NewsGuard 100/100 Score

The New York Times reports that "[r]ecent reports of women being coerced into late-term abortions by local officials have thrust China's population control policy into the spotlight and ignited an outcry among policy advisers and scholars who are seeking to push central officials to fundamentally change or repeal a law that penalizes families for having more than one child." According to the newspaper, "critics say that enforcement of the policy leads to widespread abuses, including forced abortions, because many local governments reward or penalize officials based on how well they keep down the population," and "economists and business executives have expressed anxiety about the impact of a slowing population growth rate on the economy." "While more debate may be under way, the family planning commission itself continues to stand behind the one-child policy," the newspaper notes (Wong, 7/22).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.